Central Heyu Reproductive Medicine Center Review: Hong Kong Assisted Reproduction Service Process and Real Patient Experience Analysis

AI Summary

Main Content Begins

Initial examination report of a 36-year-old woman shows: AMH 1.8 ng/mL, FSH 7.6 IU/L, basal antral follicle count (AFC) 5 on the left and 4 on the right, semen analysis indicating mild oligoasthenozoospermia. She is comparing several reproductive medicine centers in Hong Kong, with Central Heyu Reproductive Medicine Center being a key consideration. For this ovarian reserve status and male factor, what medical and technical details should be focused on when choosing a reproductive center?

How to Evaluate a Reproductive Medicine Center: Core Dimensions

Answering "How is Central Heyu Reproductive Medicine Center?" cannot be separated from an objective evaluation framework. The level of a reproductive medicine center is mainly reflected in the following dimensions:

• Embryology Laboratory Quality Control Standards: Laboratory environment (air quality, temperature, humidity control), incubator type (e.g., time-lapse imaging incubators), operator experience. Laboratory quality directly affects embryo developmental potential and blastocyst formation rate.
• Expertise Coverage of the Medical Team: Whether there is a collaborative team with backgrounds in reproductive endocrinology, embryology, genetic counseling, and andrology. The team composition is particularly crucial for patients of advanced maternal age, those with recurrent implantation failure, or those requiring genetic disease screening.
• Ability for Individualized Medication and Protocol Adjustment: Whether the ovarian stimulation protocol is formulated based on AMH, FSH, antral follicle count, and previous cycle response, rather than using a fixed template.
• Patient Communication and Process Transparency: Whether communication at each stage from initial consultation to transfer is clear, whether examination result interpretation is specific, and whether the cost structure is clear.

Medical Quality Indicators that Reproductive Medicine Specialists Focus On

From a reproductive doctor's perspective, when evaluating a center, priority is given to the following three levels:

1. Laboratory Key Performance Indicators (KPIs)

• Fertilization Rate: IVF fertilization rate is generally 70%-85%, ICSI 75%-90%. Rates below this range require investigation of laboratory or gamete factors.
• Blastocyst Formation Rate: The high-quality blastocyst formation rate reflects the stability of the culture system. For day 3 embryos, the proportion forming blastocysts should be 40%-60%.
• Frozen-Thawed Embryo Survival Rate: In centers proficient in vitrification technology, the survival rate should be above 95%.

2. Degree of Individualization of Ovarian Stimulation Protocols

Doctors choose long GnRH agonist protocols, short protocols, GnRH antagonist protocols, or PPOS protocols based on the patient's AMH, antral follicle count, age, and previous response. For patients with diminished ovarian reserve (AMH <1.0 ng/mL), mild stimulation or natural cycle protocols may be more suitable. The flexibility of the medical team at Central Heyu Reproductive Medicine Center in adjusting protocols can be assessed during the initial consultation discussion.

3. Integration of Genetic Counseling and PGT

For patients with chromosomal translocations, single gene disorders, or a history of recurrent miscarriage, whether the center provides genetic counseling and Preimplantation Genetic Testing (PGT-A/PGT-M) services, along with post-test result interpretation and transfer recommendations, is an important medical quality indicator.

Key Focus Areas for Patients of Different Age Groups

Central Heyu Reproductive Medicine Center demonstrates protocol suitability for the 35-42 age group with its individualized medication and genetic testing integration capabilities, but this needs to be confirmed based on initial examination results.

Consultation Process at a Hong Kong Assisted Reproduction Center

Taking Central Heyu Reproductive Medicine Center as an example, the standard consultation process is divided into the following stages:

1. Initial Consultation and Fertility Assessment (1st Visit): Includes female AMH, FSH, LH, Estradiol, thyroid function, infectious disease screening, vaginal ultrasound for antral follicle count; male semen analysis, infectious disease screening. It is recommended to bring all previous examination reports.
2. Formulating the Ovarian Stimulation Protocol (2nd Visit): The doctor discusses and finalizes the ovarian stimulation protocol based on examination results, age, ovarian reserve, and male factors. File creation and signing of informed consent are also completed.
3. Ovarian Stimulation and Monitoring (Approximately 10-14 days): Starting from day 2-3 of menstruation, ovarian stimulation medication is injected. Return to the clinic every 2-4 days for monitoring follicular development and hormone levels, with medication adjustments as needed.
4. Egg Retrieval Surgery (Outpatient Procedure): After follicle maturation, HCG or GnRH agonist is injected. Ultrasound-guided egg retrieval is performed 36 hours later, usually under intravenous sedation. Patients can be discharged after 1-2 hours of observation.
5. Embryo Culture and Testing (5-7 days post egg retrieval): Sperm is collected on the day of egg retrieval for IVF or ICSI fertilization. Embryos are cultured to the blastocyst stage on day 5-6. Biopsy is performed if PGT is required.
6. Frozen Embryo Transfer (Subsequent Cycle): Depending on endometrial preparation, frozen embryo transfer is performed in the next or a subsequent cycle. Pregnancy test is done 10-12 days after transfer.
7. Luteal Phase Support and Follow-up: Luteal phase support continues after transfer until the pregnancy test. After confirming pregnancy, gradually transition to obstetric follow-up.

Time Planning Schedule

The time schedule from initial consultation to completing one frozen embryo transfer cycle is as follows:

How far in advance should I prepare? It is recommended to complete all examinations (including chromosome, hysteroscopy, infectious disease screening) at least 3 months in advance, and ensure your passport/Mainland China Travel Permit for Hong Kong and Macau is valid for more than 6 months. For patients of advanced maternal age or with diminished ovarian reserve, starting the assessment earlier is advised.

Key Examination Indicators and Their Clinical Significance

In the initial assessment, the following indicators directly determine protocol selection and cycle planning:

• AMH (Anti-Müllerian Hormone): An objective indicator of ovarian reserve. AMH >2.0 ng/mL suggests good reserve; 1.0-2.0 ng/mL is moderate; <1.0 ng/mL indicates diminished reserve; <0.5 ng/mL indicates severely diminished reserve. AMH is not affected by the menstrual cycle and can be tested at any time.
• FSH (Follicle-Stimulating Hormone): Basal FSH (day 2-3 of menstruation) >10 IU/L suggests decreased ovarian response. Combining FSH and AMH provides a more accurate assessment than either indicator alone.
• Basal Antral Follicle Count (AFC): Number of antral follicles (2-10mm) measured by vaginal ultrasound on day 2-3 of menstruation. AFC >10 is normal, 5-10 is reduced, <5 is significantly reduced.
• Semen Analysis: Includes sperm concentration, motility (percentage of progressive motility), morphology (percentage of normal forms). WHO 6th edition standards: concentration ≥16 million/mL, total motility ≥42%, progressive motility ≥30%, normal morphology ≥4%.
• Chromosome Karyotype Analysis: To rule out structural abnormalities such as balanced translocations, Robertsonian translocations. Recommended for both partners in cases of recurrent miscarriage or repeated implantation failure.
• Hysteroscopy: To rule out factors affecting embryo implantation such as intrauterine adhesions, polyps, fibroids. It is recommended to complete this before ovarian stimulation.

Details Most Easily Overlooked During the Consultation Process

Based on practitioner observations, the following details are often overlooked by patients but have a direct impact on cycle progress:

• Document Validity and Endorsement Type: Traveling to Hong Kong for medical consultation requires a Mainland China Travel Permit for Hong Kong and Macau with a valid endorsement. Individual Travel Endorsement (G签) allows a maximum stay of 7 days per visit; Group Tour Endorsement (L签) requires entry and exit with a tour group. Confirm the remaining number of endorsements and validity period in advance. Some examinations require multiple trips, so ensure sufficient endorsements.
• Timeliness of Examination Reports: Reports for AMH and infectious disease screening (Hepatitis B, HIV, Syphilis, etc.) are valid for 6-12 months; chromosome karyotype is valid for life. If planning to start the cycle in 3 months, complete examinations early, but be aware that some tests should not be done too early to avoid expiration.
• Completeness of Male Partner Examinations: Semen analysis requires 2-5 days of abstinence; too short or too long an abstinence period can affect results. It is also recommended to add Sperm DNA Fragmentation Index (DFI) testing; DFI >30% is associated with increased miscarriage rates.
• Confirmation of Luteal Phase Support Protocol: Luteal phase support after transfer includes oral, vaginal gel, or injection methods. The blood concentration and convenience differ; confirm with the doctor before transfer.
• Confirmation of Communication Language: The common languages in Hong Kong medical institutions are Cantonese and English. Some centers offer Mandarin services. Confirm language support for subsequent communication during the initial consultation to avoid information transfer errors.

Frequently Asked Questions